That’s why Pfizer is behind the whole waving of intellectual property rights so they don’t have to pay Biontech a dime and why the German government is against the waving of rights.
Which brings me to the second question. Is the proposed waiver going to improve the supply situation or create more problems? And my answer is categorically the latter.
https://www.pfizer.com/news/hot-topics/why_pfizer_opposes_th...
Specifically this section:
Which brings me to the second question. Is the proposed waiver going to improve the supply situation or create more problems? And my answer is categorically the latter.